Question 1

Am I eligible for this trial based on my recent stroke?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Rivaroxaban Versus Aspirin in Secondary Prevention of Stroke and Prevention of Systemic Embolism in Patients With Recent Embolic Stroke of Undetermined Source (ESUS) clinical trial (NCT02313909). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential benefits and risks of participating in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Rivaroxaban Versus Aspirin in Secondary Prevention of Stroke and Prevention of Systemic Embolism in Patients With Recent Embolic Stroke of Undetermined Source (ESUS) clinical trial (NCT02313909). Contact the study team or your healthcare provider for specific answers.

Question 3

How does Rivaroxaban compare to other treatments I might be considering?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Rivaroxaban Versus Aspirin in Secondary Prevention of Stroke and Prevention of Systemic Embolism in Patients With Recent Embolic Stroke of Undetermined Source (ESUS) clinical trial (NCT02313909). Contact the study team or your healthcare provider for specific answers.

Question 4

What will my treatment and follow-up look like if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Rivaroxaban Versus Aspirin in Secondary Prevention of Stroke and Prevention of Systemic Embolism in Patients With Recent Embolic Stroke of Undetermined Source (ESUS) clinical trial (NCT02313909). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any specific side effects I should be aware of with Rivaroxaban or Aspirin?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Rivaroxaban Versus Aspirin in Secondary Prevention of Stroke and Prevention of Systemic Embolism in Patients With Recent Embolic Stroke of Undetermined Source (ESUS) clinical trial (NCT02313909). Contact the study team or your healthcare provider for specific answers.

What this study is about